These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32240455)

  • 1. Metformin is distributed to tumor tissue in breast cancer patients in vivo: A
    Sundelin EIO; Al-Suliman N; Vahl P; Vendelbo M; Munk OL; Jakobsen S; Pedersen SB; Frøkiær J; Gormsen LC; Jessen N
    Breast Cancer Res Treat; 2020 May; 181(1):107-113. PubMed ID: 32240455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease.
    Sundelin EIO; Gormsen LC; Heebøll S; Vendelbo MH; Jakobsen S; Munk OL; Feddersen S; Brøsen K; Hamilton-Dutoit SJ; Pedersen SB; Grønbaek H; Jessen N
    Br J Clin Pharmacol; 2019 Aug; 85(8):1761-1770. PubMed ID: 30973968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency.
    Jensen JB; Sundelin EI; Jakobsen S; Gormsen LC; Munk OL; Frøkiær J; Jessen N
    Diabetes; 2016 Jun; 65(6):1724-30. PubMed ID: 26993065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.
    Chen EC; Liang X; Yee SW; Geier EG; Stocker SL; Chen L; Giacomini KM
    Mol Pharmacol; 2015 Jul; 88(1):75-83. PubMed ID: 25920679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.
    Breining P; Jensen JB; Sundelin EI; Gormsen LC; Jakobsen S; Busk M; Rolighed L; Bross P; Fernandez-Guerra P; Markussen LK; Rasmussen NE; Hansen JB; Pedersen SB; Richelsen B; Jessen N
    Diabetes Obes Metab; 2018 Sep; 20(9):2264-2273. PubMed ID: 29752759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats.
    Ma YR; Huang J; Shao YY; Ma K; Zhang GQ; Zhou Y; Zhi R; Qin HY; Wu XA
    Eur J Pharm Sci; 2015 Feb; 68():18-26. PubMed ID: 25486332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PET Tracer for Renal Organic Cation Transporters, ¹¹C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    Jakobsen S; Busk M; Jensen JB; Munk OL; Zois NE; Alstrup AK; Jessen N; Frøkiær J
    J Nucl Med; 2016 Apr; 57(4):615-21. PubMed ID: 26769859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
    Markowicz-Piasecka M; Huttunen J; Sikora J; Huttunen KM
    Bioorg Chem; 2019 Jun; 87():321-334. PubMed ID: 30913467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lonicera japonica extract increases metformin distribution in the liver without change of systemic exposed metformin in rats.
    Han SY; Chae HS; You BH; Chin YW; Kim H; Choi HS; Choi YH
    J Ethnopharmacol; 2019 Jun; 238():111892. PubMed ID: 31004727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [(11)C]Metformin in Mouse.
    Shingaki T; Hume WE; Takashima T; Katayama Y; Okauchi T; Hayashinaka E; Wada Y; Cui Y; Kusuhara H; Sugiyama Y; Watanabe Y
    Pharm Res; 2015 Aug; 32(8):2538-47. PubMed ID: 25715695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from
    Iversen AB; Horsman MR; Jakobsen S; Jensen JB; Garm C; Jessen N; Breining P; Frøkiær J; Busk M
    Sci Rep; 2017 Aug; 7(1):9436. PubMed ID: 28842630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses.
    Gormsen LC; Sundelin EI; Jensen JB; Vendelbo MH; Jakobsen S; Munk OL; Hougaard Christensen MM; Brøsen K; Frøkiær J; Jessen N
    J Nucl Med; 2016 Dec; 57(12):1920-1926. PubMed ID: 27469359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects.
    Baldassari S; Solari A; Zuccari G; Drava G; Pastorino S; Fucile C; Marini V; Daga A; Pattarozzi A; Ratto A; Ferrari A; Mattioli F; Barbieri F; Caviglioli G; Florio T
    Sci Rep; 2018 Mar; 8(1):3929. PubMed ID: 29500390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.
    Lord SR; Cheng WC; Liu D; Gaude E; Haider S; Metcalf T; Patel N; Teoh EJ; Gleeson F; Bradley K; Wigfield S; Zois C; McGowan DR; Ah-See ML; Thompson AM; Sharma A; Bidaut L; Pollak M; Roy PG; Karpe F; James T; English R; Adams RF; Campo L; Ayers L; Snell C; Roxanis I; Frezza C; Fenwick JD; Buffa FM; Harris AL
    Cell Metab; 2018 Nov; 28(5):679-688.e4. PubMed ID: 30244975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    De Bruycker S; Vangestel C; Van den Wyngaert T; Pauwels P; Wyffels L; Staelens S; Stroobants S
    J Nucl Med; 2019 Jan; 60(1):34-40. PubMed ID: 29980581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
    Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM
    J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies.
    Zhang G; Ma Y; Xi D; Rao Z; Sun X; Wu X
    Biopharm Drug Dispos; 2019 Jan; 40(1):3-11. PubMed ID: 30488476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.